GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 5 filers reported holding GENETIC TECHNOLOGIES LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15 | -21.1% | 18,182 | +14.6% | 0.00% | -50.0% |
| Q1 2023 | $19 | -99.9% | 15,864 | +53.9% | 0.00% | +100.0% |
| Q1 2022 | $20,000 | -51.2% | 10,310 | -22.8% | 0.00% | -75.0% |
| Q3 2021 | $41,000 | -50.6% | 13,357 | -44.2% | 0.00% | -71.4% |
| Q3 2020 | $83,000 | +107.5% | 23,954 | +35.4% | 0.01% | +180.0% |
| Q2 2020 | $40,000 | – | 17,689 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scarborough Advisors, LLC | 10,638 | $8,113 | 0.00% |
| RHUMBLINE ADVISERS | 18,700 | $14,378 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 87,656 | $66,846 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 15,844 | $12,083 | 0.00% |